Literature DB >> 29092940

DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach.

Dinler A Antunes1, Mark Moll1, Didier Devaurs1, Kyle R Jackson2, Gregory Lizée2, Lydia E Kavraki3.   

Abstract

Molecular docking is a standard computational approach to predict binding modes of protein-ligand complexes by exploring alternative orientations and conformations of the ligand (i.e., by exploring ligand flexibility). Docking tools are largely used for virtual screening of small drug-like molecules, but their accuracy and efficiency greatly decays for ligands with more than 10 flexible bonds. This prevents a broader use of these tools to dock larger ligands, such as peptides, which are molecules of growing interest in cancer research. To overcome this limitation, our group has previously proposed a meta-docking strategy, called DINC, to predict binding modes of large ligands. By incrementally docking overlapping fragments of a ligand, DINC allowed predicting binding modes of peptide-based inhibitors of transcription factors involved in cancer. Here, we describe DINC 2.0, a revamped version of the DINC webserver with enhanced capabilities and a more user-friendly interface. DINC 2.0 allows docking ligands that were previously too challenging for DINC, such as peptides with more than 25 flexible bonds. The webserver is freely accessible at http://dinc.kavrakilab.org, together with additional documentation and video tutorials. Our team will provide continuous support for this tool and is working on extending its applicability to other challenging fields, such as personalized immunotherapy against cancer. Cancer Res; 77(21); e55-57. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29092940      PMCID: PMC5679007          DOI: 10.1158/0008-5472.CAN-17-0511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Docking small peptides remains a great challenge: an assessment using AutoDock Vina.

Authors:  Robert Rentzsch; Bernhard Y Renard
Journal:  Brief Bioinform       Date:  2015-04-21       Impact factor: 11.622

Review 2.  The future of peptide-based drugs.

Authors:  David J Craik; David P Fairlie; Spiros Liras; David Price
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

Review 3.  Virtual Screening Techniques and Current Computational Infrastructures.

Authors:  Jason H Haga; Kohei Ichikawa; Susumu Date
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 4.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

Review 5.  Gut hormone GPCRs: structure, function, drug discovery.

Authors:  Arnau Cordomí; Daniel Fourmy; Irina G Tikhonova
Journal:  Curr Opin Pharmacol       Date:  2016-09-16       Impact factor: 5.547

6.  Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand.

Authors:  M S Plummer; D R Holland; A Shahripour; E A Lunney; J H Fergus; J S Marks; P McConnell; W T Mueller; T K Sawyer
Journal:  J Med Chem       Date:  1997-11-07       Impact factor: 7.446

Review 7.  Harnessing the power of the immune system to target cancer.

Authors:  Gregory Lizée; Willem W Overwijk; Laszlo Radvanyi; Jianjun Gao; Padmanee Sharma; Patrick Hwu
Journal:  Annu Rev Med       Date:  2012-10-22       Impact factor: 13.739

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  DINC: a new AutoDock-based protocol for docking large ligands.

Authors:  Ankur Dhanik; John S McMurray; Lydia E Kavraki
Journal:  BMC Struct Biol       Date:  2013-11-08

10.  Binding modes of peptidomimetics designed to inhibit STAT3.

Authors:  Ankur Dhanik; John S McMurray; Lydia E Kavraki
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more
  27 in total

1.  Extensive benchmark of rDock as a peptide-protein docking tool.

Authors:  Daniel Soler; Yvonne Westermaier; Robert Soliva
Journal:  J Comput Aided Mol Des       Date:  2019-07-03       Impact factor: 3.686

2.  Methods for Molecular Modelling of Protein Complexes.

Authors:  Tejashree Rajaram Kanitkar; Neeladri Sen; Sanjana Nair; Neelesh Soni; Kaustubh Amritkar; Yogendra Ramtirtha; M S Madhusudhan
Journal:  Methods Mol Biol       Date:  2021

3.  HLA-Arena: A Customizable Environment for the Structural Modeling and Analysis of Peptide-HLA Complexes for Cancer Immunotherapy.

Authors:  Dinler A Antunes; Jayvee R Abella; Sarah Hall-Swan; Didier Devaurs; Anja Conev; Mark Moll; Gregory Lizée; Lydia E Kavraki
Journal:  JCO Clin Cancer Inform       Date:  2020-07

4.  Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM.

Authors:  Vikram Dalal; Poonam Dhankhar; Vishakha Singh; Vishakha Singh; Gaddy Rakhaminov; Dasantila Golemi-Kotra; Pravindra Kumar
Journal:  Protein J       Date:  2021-01-09       Impact factor: 2.371

5.  Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.

Authors:  Poonam Dhankhar; Vikram Dalal; Viney Kumar
Journal:  J Comput Biol       Date:  2021-11-29       Impact factor: 1.479

Review 6.  Structural Prediction of Peptide-MHC Binding Modes.

Authors:  Marta A S Perez; Michel A Cuendet; Ute F Röhrig; Olivier Michielin; Vincent Zoete
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.

Authors:  Maxence Delaunay; Tâp Ha-Duong
Journal:  Methods Mol Biol       Date:  2022

8.  Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma.

Authors:  Aviyah Peri; Erez Greenstein; Michal Alon; Joy A Pai; Tamir Dingjan; Shlomit Reich-Zeliger; Eilon Barnea; Chaya Barbolin; Ronen Levy; Claudia Arnedo-Pac; Shelly Kalaora; Bareket Dassa; Ester Feldmesser; Ping Shang; Polina Greenberg; Yishai Levin; Gil Benedek; Mitchell P Levesque; David J Adams; Michal Lotem; James S Wilmott; Richard A Scolyer; Göran B Jönsson; Arie Admon; Steven A Rosenberg; Cyrille J Cohen; Masha Y Niv; Nuria Lopez-Bigas; Ansuman T Satpathy; Nir Friedman; Yardena Samuels
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

9.  General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept.

Authors:  Dinler A Antunes; Didier Devaurs; Mark Moll; Gregory Lizée; Lydia E Kavraki
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

10.  Self-Assembling Systems Based on Pillar[5]arenes and Surfactants for Encapsulation of Diagnostic Dye DAPI.

Authors:  Anastasia Nazarova; Arthur Khannanov; Artur Boldyrev; Luidmila Yakimova; Ivan Stoikov
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.